 Hi, in this video, we will learn about the AML treatment. There are some things in AML that we need to know about. What we need to know is that there is only one treatment for AML M3 or APML. We will teach the rest separately. So, now we will not talk about AML M3, but about AML treatment. We will talk about how we will do it in this video. So, as we have said in the previous videos, there will be stages for AML blood cancer, migratha cancer, breast cancer etc. So, we will make them a risk stratification. We need to intensify the treatment that we have done. Otherwise, we need to respond to the treatment that we are doing. To know what it is. So, we will do the chromosome test, molecular test and carry-out test. We will do that and we will be able to perform the AML treatment in 3 parts. 1. Good or favorable risk. 2. Intermediate risk. 3. Poor or adverse risk. So, we will do the chromozoams, molecular test and carry-out test. We will make them a risk stratification in 3 parts. But, the treatment that we have done is the risk stratification. The treatment that we have done is induction therapy. This induction therapy is usually done in 3 plus 7 chemotherapy. So, it is done in 3 days. After 3 days, it is done in 7 days. There are some modifications to the AML treatment in 3 plus 7. But, what we need to know is, the induction therapy is a risk stratification. It is a risk group treatment. It is an induction therapy for everyone. If the FLT3 is positive for anyone, it is a risk stratification for induction chemotherapy. After giving chemotherapy, the WBC counts are reduced and the recovery time is 3 to 4 hours. After 4 hours, bone marrow test is done. It is a risk stratification for everyone. There are less than 5% of cancer cells in bone marrow. WBC counts are good. There are more than 1,000,000. If it is like this, we will tell them as we have seen the complete remission. We do not know the bone marrow. So, we call it CGR. It is an induction therapy. After completing the remission, we will tell about the treatment. For people with good risk or favorable risk, there are additional 3 courses of chemotherapy. This is a consolidation therapy. In this consolidation therapy, for people with high dosa, there are 3 courses of chemotherapy for people with good or favorable risk. We will tell about it in their observation. For people with intermediate or poor risk, they need bone marrow transplantation. For people with good or favorable risk, we will do an induction and do bone marrow transplantation. If we do a consolidation therapy and do an observation, the success rate will be around 50%. So, there will be a complete treatment of 50% of cancer cells. For people with intermediate or poor risk, we will do an induction and do bone marrow transplantation. If we do a consolidation therapy and do bone marrow transplantation, the success rate will be around 25-30%. So, there will be a complete treatment of 30 people from 125 to 30 people. For people with poor or adverse risk, we will do bone marrow transplantation and do bone marrow transplantation. If we do bone marrow transplantation, we will have a complete treatment fromStop agents. We can name it, but it is upto these people,